Organic Regenerative Medicine: Responds to Recent Promotional Activities According to OTC Market Demand – Form 8-K

Organicell Regenerative Medicine, Inc. For recent promotional activities according to the demand of OTC markets

Davie, FL – November 21, 2022 – Organicell Regenerative Medicine, Inc. (OTCQB: OCEL) (“ORGANICAL OR THE COMPANYOrdered by OTC Markets Group, Inc. (“OTC markets) to issue this statement of promotional activity relating to its regular inventory.

On November 17, 2022, OTC Markets notified the Company to distribute three promotional email newsletters (“Newsletters”), each dated November 15, 2022. The three email newsletters were published by Wall Street Alerts, Epic Stocks Picks, and Green Leaf Stocks. Pot, respectively, and discussed, among other things, the Company, its current and planned products, the potential market for its products, and the potential for upside in the trading price of the stock. The publications also included a summary of several of the company’s recent press releases. OTC Markets has provided the company with newsletters for your reference. The company was not aware of the news releases prior to receiving them from OTC Markets.

The Company takes its investor relations practices seriously, including its obligations to timely and accurately release material information that could reasonably be expected to have a significant impact on the market price or value of its securities. The specific claims in the news releases regarding the company’s stock and how much it will appreciate are highly speculative and should be carefully evaluated based on the company’s most recent filings on sec.gov.

The Company has been a fully reporting, periodic reporting company under Section 13 of the Securities Act of 1934, since June 2013 and its ordinary shares have been listed on the OTCQB since November 9, 2021.

In connection with the Company’s efforts to increase awareness of its brand and company in the investment community and stock markets, in August 2022, the Company engaged TraDigital Marketing Group (“TraDigital Marketing Group”).TraDigitalTo provide investor and public relations services designed to assist Organicell in achieving its goal of raising the company’s profile in the investment community and stock markets, though, among other actions, to make introductions to investment banks, brokerage firms, dealers, attorneys, consultants, public relations firms, and public relations firms Investors, brand awareness firms, and digital marketing firms.

From August through November 2022, TraDigital and its affiliate company worked with several companies to raise awareness of the company. In addition, as required of a public company, Organicell issued a number of press releases during that period, reporting material developments and achievements, most of which were also filed under the guise of current reporting on Form 8-K with the Securities and Exchange Commission. These press releases are also included on the company’s page on the OTC Markets website.

To assist TraDigital in its efforts on behalf of the Company, Organic has provided TraDigital with copies of its periodic reports filed with the SEC, its press releases and investor presentation filed with the SEC as “7.01 FD Regulation DisclosureIn the current report on Form 8-K on October 12, 2022.

As part of its involvement, TraDigital and its affiliates have engaged one or more third-party companies to provide marketing services.

To the Company’s knowledge, Wall Street Alerts, Epic Stock Picks, and Green Leaf Pot Stocks are a third-party marketing and advertising company that provides content distribution and advertising services. Epic Stock Picks and Green Leaf Pot Stocks each state that their newsletters are owned and operated by Link Media.

Each of the news releases provided factual statements regarding the Company, its current and planned business and industry, which appear to have been derived from SEC filings. Neither the Company nor TraDigital have viewed the Material or have any editorial control over it, nor have they reviewed the Material for factual accuracy or even viewed it prior to its publication. While the Company does not believe that the factual statements contained in the newsletters that were based on Organicell’s SEC filings and press releases were false or misleading, both newsletters included information and language that went beyond the factual statements in the Company’s SEC filings and press releases. As noted, neither the Company nor TraDigital had any control over the content of the promotional materials.

The Company has no knowledge or opinion as to whether the newsletters affected trading activity, however, the Company acknowledges that the trading volume on November 15, 2022, the date the newsletters were published, was significantly higher than the previous daily volume levels, and that the trading price witnessed An increase on that date compared to the previous trading days.

As noted, neither the Company nor its officers or directors were involved in creating the information in the e-mail newsletters, other than information obtained from SEC filings and press releases, which were prepared and issued by the Company.

After due inquiry, the Company confirms that it is not aware of any of the Controlled Persons, officers, directors, or any shareholders who own 10% or more of the securities of the Company, and who may, directly or indirectly, be involved in any way in creating or Distributing promotional materials relating to the Company and its securities, other than preparing the Company’s SEC filings and related press releases, the substance of which is contained in the indicated newsletters. As noted above, TraDigital and its affiliate partnered with the third-party marketing company that participated in Wall Street Alerts, Epic Stock Picks, Green Leaf Pot Stocks, and advanced funds for the third-party marketing company to partially pay for marketing services. However, neither TraDigital nor its affiliate is involved in creating or distributing email newsletters or other promotional materials.

After due inquiry of management, directors, controlling persons and any third party service providers, the Company can confirm that neither the Company nor the controlling persons, officers, directors, controlling shareholders or any third party service providers have sold or purchased securities of the Company during the past 90 days , except for transactions reported in the company’s SEC filings.

Other than as disclosed above, the Company has not engaged any third party providers to provide investor relations services, public relations services, marketing or other related services including promotion of the Company or its securities in the past twelve months.

Since August 2022, the Company has not issued any shares of common stock or convertible instruments allowing conversion into equity securities at prices that are a discount to the current market price at the time of issuance.

About Organicell Regenerative Medicines, Inc.

Organicell Regenerative Medicine, Inc. (OTCQB: OCEL) is a clinical-stage biopharmaceutical company primarily focused on developing innovative biological therapies for the treatment of degenerative diseases and providing other related services. The Company’s proprietary products are derived from perinatal sources and formulated to retain naturally occurring exosomes, hyaluronic acid, and proteins without the addition or blend of any other substance or diluent. To find out more, please visit https://organicell.com/.

Forward-looking statements

Certain statements in this press release should be considered forward-looking statements within the meaning of the Securities Exchange Act of 1933, as amended (“Securities law”), the Securities Exchange Act of 1934 and its amendments (“exchange law”), and the Private Securities Litigation Reform Act of 1995. These forward-looking statements are often identified by the use of forward-looking terminology such as “will,” “believe,” “expect,” “potential,” or similar expressions, which involve known risks and uncertainties Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they involve assumptions, risks and uncertainties, and these expectations may be incorrect.We remind you that actual results can differ materially as a result of known and unknown risks and uncertainties, including This includes but is not limited to: Potential issues related to our financial condition, competition, ability to retain key employees, product safety, effectiveness and acceptability, commercial success of any new products or technologies, success of clinical programs, ability to retain key customers, our inability to expand channels Sales and distribution, legislation or regulation affecting our operations including product pricing, payment or access, ability to protect patents and other intellectual property globally domestic and international, and other known and unknown risks and uncertainties, including risk factors discussed in the company’s periodic reports filed with the SEC and available on the SEC’s website (http://www.sec.gov). You are cautioned not to place undue reliance on these forward-looking statements. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. The specific information contained in this press release may change over time and may or may not be accurate after the date of issue. Organicell specifically disclaims any intention to update the information in this press release.

Investor relations and media relations

Organic Investor Relations
1-888-963-7881 ext. 701
IR@organicell.com

Leave a Comment